Summary:
Bidding For Renting Automatic Blood Bank Analysis Equipment With Reagents By Electronic Bidding Method Country:
Thailand Estimated Cost:
THB 16824850 Notice Type:
Procurement Plan Deadline:
19 Sep 2025 Posting Date:
20 Sep 2024 |
Summary:
Bidding For Rental Of Blood Bank Analysis Equipment And Reagents, 2 Items, By Electronic Bidding Method. Country:
Thailand Estimated Cost:
THB 4340000 Notice Type:
Procurement Plan Deadline:
16 Jul 2025 Posting Date:
17 Jul 2024 |
Summary:
Supply of Medicine and Medical / Surgical equipments : Elisa Test kit for detection of HIV P24 antigen\nand antibodies to HIV; HIV 2 and HIV vi sub\ntype „O‟ antigen\n1. Test kit should detect of HIV P24 antigen\nand antibodies to HIV-1 (groups M and O)\nand HIV-2 inhuman serum or plasma.\n2. Number of tests shall be performed =480\ntests per kit\n3. Sensitivity should be 100%\n4. Specificity should be more than 99%\n5. Residual shelf life at the time of delivery\nshould be minimum of 18 months\n6. Each test kit should include adequate\npositive and negative controls\n7. Shall give a color change once serum is\nadded to the reagents.\n8. Precautions must be taken to maintain the\ncold chain while transportation until it reaches\nthe blood bank, as these\nreagents are kept at 2-6C.\n9. Reagent brochure, labels and any other\ninformation provided should be in English\nlanguage.\n10. Reagent shall contain FDA certification\nand/or WHO certification/ EU Quality\ncertification /free sales certificate and\ncertificate of use in the country in country of\norigin/ end user evaluation certificate/ or free\nsales certificate in USA, UK, France, Germany,\nCanada, New Zealand or Australia with\nstandard quality certificates etc . Country:
Sri Lanka
Notice Type:
Tender Notice Deadline:
24 Mar 2025 Posting Date:
14 Feb 2025 |
Summary:
Supply of Medicine and Medical / Surgical equipments : ELISA test kit for the detection of Antigen &\nAntibodies to HCV 4th Gen (Hepatitis C Virus)\n1. Test kit should detect HCV antigen and\nantibodies in human serum or plasma.\n2. Number of tests shall be performed =480\ntests per kit\n3. Sensitivity should be 100%\n4. Specificity should be more than 99%\n5. Residual shelf life at the time of delivery\nshould be minimum of 18 months\n6. Each test kit should include adequate\nnegative and positive controls\n7. Shall give a color change once serum is\nadded to the reagents.\n8. Precautions must be taken to maintain the\ncold chain while transportation until it reaches\nthe blood bank, as thesem reagents are kept\nat 2-6 C.\n9. Reagent brochure, labels and any other\ninformation provided should be in English\nlanguage.\n10. Reagent shall contain FDA certification\nand/or WHO certification/ EU Quality\ncertification /free sales certificate and\ncertificate of use in the country in country of\norigin/end user evaluation certificate/ or free\nsales certificate in USA, UK, France, Germany,\nCanada, New Zealand or Australia with\nstandard quality certificates etc . Country:
Sri Lanka
Notice Type:
Tender Notice Deadline:
24 Mar 2025 Posting Date:
14 Feb 2025 |
Summary:
Supply of Medicine and Medical / Surgical equipments : Anti C Sera 5ml/vial\n1. The method of manufacture should result\nin a product within an immediate container\nthat is homogeneous and free of properties\nwhich adversely affect its intended use\nthroughout its recommended shelf life. The\nreagent should have no precipitate, particles\nor fibrin gel.\n2. Each batch or sub-batch should be\nspecifically identified by a distinctive\ncombination of numbers and/or letters (batch\nreference) which permits its history to be\ntraced.\n3. Reagents should be produced by a\nvalidated process that is shown to be suitable\nfor the intended purpose.\n4. Volume should be mentioned in milliliters\n(ml) on immediate container\n5. Absence of rouleaux formation, prozone\nand haemolysis.\n6. Labelling requirements; A. Should have a\nlabel on the immediate container B. Printing\non all final container labels shall be in solid\nblack. C. The label fixed to the immediate\ncontainer of a reagent should leave\nuncovered sufficient area of the full length or\ncircumference of the container to allow ready\nvisual inspection of the contents. D. The\nspecificity of the reagent for blood group\nserology should be of a print size which is\nclearly legible. The print size of other\ninformation on the label should not exceed\nthat used for the specificity of the reagent. E.\nShould include Lot number and sub lot\ndesignations, if available F. Expiry date\nshould be mentioned. G. Should mention the\nrecommended storage temperature (2-6 C)\n7. Precautions must be taken to maintain the\ncold chain while transportation until it reaches\nthe blood bank, as these reagents are kept at\n2-6C.\n8. Reagent shall contain FDA and/or WHO\ncertification/ country of origin certificate and\ncertificate of use in the country of origin/end\nuser evaluation certificate/free sales\ncertificate in USA, UK, France, Germany,\nCanada, New Zealand or Australia with\nstandard quality certificates.\n9. Reagent brochure, l Country:
Sri Lanka
Notice Type:
Tender Notice Deadline:
24 Mar 2025 Posting Date:
14 Feb 2025 |
Summary:
Supply of Medicine and Medical / Surgical equipments : Anti-A Blood grouping Reagent- Monoclonal-\nDirect Agglutining 10ml\n1. The method of manufacture should result\nin a product within an immediate container\nthat is homogeneous and free of properties\nwhich adversely affect its intended use\nthroughout its recommended shelf life. The\nreagent should have no precipitate, particles\nor fibrin gel.\n2. Each batch or sub-batch should be\nspecifically identified by a distinctive\ncombination of numbers and/or letters (batch\nreference) which permits its history to be\ntraced.\n3. Reagents should be produced by a\nvalidated process that is shown to be suitable\nfor the intended purpose.\n4. Volume should be mentioned in milliliters\n(ml) on immediate container\n5. Absence of rouleaux formation, prozone\nand haemolysis.\n6. Labelling requirements; A. Should have a\nlabel on the immediate container B. Printing\non all final container labels shall be in solid\nblack. C. The label fixed to the immediate\ncontainer of a reagent should leave\nuncovered sufficient area of the full length or\ncircumference of the container to allow ready\nvisual inspection of the contents. D. The\nspecificity of the reagent for blood group\nserology should be of a print size which is\nclearly legible. The print size of other\ninformation on the label should not exceed\nthat used for the specificity of the reagent.\nE. Should include Lot number and sub lot\ndesignations, if available F. Expiry date\nshould be mentioned. G. Should mention the\nrecommended storage temperature (2-6 C)\n7. Precautions must be taken to maintain the\ncold chain while transportation until it reaches\nthe blood bank, as these reagents are kept at etc . Country:
Sri Lanka
Notice Type:
Tender Notice Deadline:
24 Mar 2025 Posting Date:
14 Feb 2025 |
Summary:
Supply of Medicine and Medical / Surgical equipments : ELISA kit for Hepatitis B, HBs antigen detection\nin human serum or plasma 480 tests/kit\n1. Test kit should detect surface antigen of the\nHepatitis B virus (HBs Ag)in human serum or\nplasma.\n2. Number of tests shall be performed =480\ntests per kit.\n3. Sensitivity should be 100%.\n4. Specificity should be more than 99%.\n5. Residual shelf life at the time of delivery\nshould be minimum of 18 months.\n6. Each test kit should include adequate\nnegative and positive controls.\n7. Shall give a color change once serum/plasma\nis added to the reagents.\n8. Precautions must be taken to maintain the\ncold chain while transportation until it reaches\nthe blood bank, as these reagents are kept at\n2-6 C.\n9. Reagent brochure, labels and any other\ninformation provided should be in English\nlanguage.\n10. Reagent shall contain FDA certification\nand/or WHO certification/ EU Quality\ncertification /free sales certificate and certificate\nof use in the country in country of origin/end\nuser evaluation certificate/ or free sales\ncertificate in USA, UK, France, Germany,\nCanada, New Zealand or Australia with\nstandard quality certificates.\nPacking : 1 pack etc . Country:
Sri Lanka
Notice Type:
Tender Notice Deadline:
24 Mar 2025 Posting Date:
14 Feb 2025 |
Summary:
Supply Of Equipment For The Transfusion System Network In The Basilicata Region. Country:
Italy
Notice Type:
Tender Notice Deadline:
18 Mar 2025 Posting Date:
14 Feb 2025 |
Summary:
Rental Of Coagulation Equipment With Transfer Of Reagents For The Alagoas Blood Bank Country:
Brazil
Notice Type:
Tender Notice Deadline:
27 Feb 2025 Posting Date:
12 Feb 2025 |
Summary:
Reagents, Supplies, Controls And Equipment Service Country:
Chile Estimated Cost:
CLP 33077240 Notice Type:
Tender Notice Deadline:
18 Feb 2025 Posting Date:
11 Feb 2025 |
Blood Bank Equipments Tenders and Bids
Find blood bank equipments tenders and government contracts. Search for business opportunities for blood bank equipments tenders..